Veran Medical Technologies Inc., a privately-held medical device company and leader in image-guided endobronchial and percutaneous technology for diagnosis of lung cancer and therapy delivery, has completed a $30.6 million financing, led by Versant Ventures and River Cities Capital Funds
(PRWeb September 22, 2015)
Read the full story at http://www.prweb.com/releases/2015/09/prweb12973645.htm
For more information, please visit
http://www.prweb.com/releases/2015/09/prweb12973645.htm